> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Medtronic Recalls Infusion Sets Due to Defective Component
- URL: https://www.fdaweb.com/medtronic-recalls-infusion-sets-due-to-defective-component/
- Published: 2017-09-13T12:00:00.000Z
- Updated: 2026-09-14T22:49:46.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5139617

Medtronic has recalled several lots of infusion sets used with all models of Medtronic insulin pumps. The recall is related to a discontinued component, vent membrane, in the infusion sets and does not include insulin pumps or glucose sensors, according to a [recall notice](http://links.govdelivery.com/track?type=click&enid=ZWFzPTEmbWFpbGluZ2lkPTIwMTcwOTEyLjc4MDU1MzIxJm1lc3NhZ2VpZD1NREItUFJELUJVTC0yMDE3MDkxMi43ODA1NTMyMSZkYXRhYmFzZWlkPTEwMDEmc2VyaWFsPTE3NDQ4OTgwJmVtYWlsaWQ9ZGF2aWRAZmRhd2ViLmNvbSZ1c2VyaWQ9ZGF2aWRAZmRhd2ViLmNvbSZmbD0mZXh0cmE9TXVsdGl2YXJpYXRlSWQ9JiYm&&&100&&&https://www.fda.gov/Safety/Recalls/ucm575731.htm?source=govdelivery&utm%5Fmedium=email&utm%5Fsource=govdelivery). The vent membrane “may be susceptible to being blocked by fluid during the process of priming/fill-tubing,” it says, adding that this can lead to potential over-delivery of insulin shortly after an infusion set change, which may cause hypoglycemia. Currently manufactured infusion sets, which have been available to patients since April, include a design update for the membrane that Medtronic says reduces the risk of insulin over-delivery after an infusion set change.